The news that Formula One legend Michael Schumacher was moved to a hospital in Paris last week for pioneering stem cell therapy has provoked a fever of hope and speculation among fans that his condition could be improved.
After suffering devastating head injuries in a ski accident almost six years ago, Schumacher was placed in a coma for six months and has been receiving treatment at his home in Switzerland. He has not been seen in public since the accident.
His privacy is closely guarded and, while it is understood he cannot walk or stand, and, according to former Ferrari manager, Jean Todt, he may still have trouble communicating, nothing has been confirmed officially.
No wonder then that fans have been so excited to hear Schumacher is now under the care of world-renowned cardiac surgeon Philippe Menasch, described as a "pioneer in cell surgery" at the Georges-Pompidou hospital in Paris.
READ MORE:* Schumacher 'conscious' after treatment*Corinna Schumacher provides rare update*Schumacher 'struggles' to communicate*Mick Schumacher trying to emulate his dad
Stem cells are cells that can differentiate or change into other types of cell, opening the possibility of replacing damaged cells with healthy ones. Scientists have been looking into their use since the Sixties, most successfully so far in cases of cancers of the blood or bone marrow. More than 26,000 patients are treated with blood stem cells in Europe each year.
And since the Eighties, skin stem cells have been used to grow skin grafts for patients with life-threatening burns; most recently, a new stem cell-based treatment to repair damage to the cornea (the surface of the eye) after an injury like a chemical burn, has received conditional approval in Europe.
But their flexibility offers hope for lots of illnesses and conditions including heart disease, MS and macular degeneration and clinical trials are progressing in all these areas. Chronic spinal cord injury is being researched with some promise, thanks to the Christopher & Dana Reeve Foundation, set up after actor Christopher Reeve was paralysed in a riding accident.
Crucially, for cases such as Schumacher, stem cells are also being explored for neurodegenerative diseases like Parkinson's and Alzheimer's and traumatic brain injuries like the one he suffered in a skiing accident in December 2013.
Head injuries are difficult to treat as brain damage cannot be undone and each case is different. Asked for comment by The Daily Telegraph, the hospital responded that they could neither confirm nor deny the presence of Schumacher.
However, if he is under the care of Menasch, it is likely he will have had stem cells delivered by an IV to the area of the body where it is felt they could work best - whether that is his head or heart.
Paris' Georges-Pompidou Hospital, where Michael Schumacher is reportedly a patient.
In a recent interview online, Menasch explained that stem cell treatment for cardiac conditions - his particular area of expertise - is in its infancy. "Nobody really knows how stem cells are working," he said. "They do not permanently transplant into the myocardium [the muscular tissue of the heart] - after a couple of days or weeks, they just disappear.
"But you still may have a functional benefit as during their transient stay in the heart," he explains in the Future Tech podcast, "as the cells release molecules into the tissue. The hypothesis is that the repair comes from the heart itself, stimulated by these molecules."
Should the stem cells have been intended for Schumacher's brain injury, research suggests that the treatment has potential. A University of Plymouth study published in the journal Cell Reports in June found that neural stem cells could be used to "wake up" and produce new neurons (nerve cells) and surrounding glial cells in the brain.
The research is in its infancy, says lead author Dr Claudia Barros, from the Institute of Translational and Stratified Medicine at the University of Plymouth, who acknowledges there is still a long way to go until such findings can be translated into human treatments.
"We are working to expand our findings, to bring us closer to the day when human neural stem cells can be controlled and efficiently used to facilitate brain damage repair, or even prevent brain cancer growth that is fuelled by stem-like cells," she says.
A Chinese study published last month in the journal Frontiers in Cellular Neuroscience examined the current state of progress into the effects of stem cell therapy on traumatic brain injury. But the researchers from Zhejiang University, Hangzhou warned much more work was needed: "Although a large number of basic studies have confirmed that stem cells have good effect in the craniocerebral injury," they said, "the safety of stem cells, the route of injection, the time of injection and the specific mechanism are all factors that affect the clinical application of stem cells, and are the important research point in the future study."
Mick Schumacher doesn't mind the comparisons with his seven-time F1 champion father Michael.
In the UK, some applications of stem cell medicine are already available privately, although tightly controlled by the Human Tissue Authority and not in the brain.
Simon Checkley, CEO at the Regenerative Clinic in Brighton, explains: "It is possible to get stem cells from sources outside your body, like the umbilical cord or Wharton's jelly [the vitreous humour in the eyeball], but in the UK we can only take stem cells from our own bodies.
"It is possible to get them donated, but it is safer to use your own."
In some countries, stem cells can then be manipulated in a laboratory but that is illegal in the UK, says Checkley. "There is a concern with cultured stem cells which have been bred in a Petri dish that they may keep proliferating after you transplant them into a body. That, having triggered their growth, you can't stop it and no one knows what might happen."
At the Regenerative Clinic, stem cells are taken from adipose fat, where they are plentiful, and then injected back into the area to be treated - mostly arthritic joints.
"We are seeing fantastic results," Checkley says, "with reduced pain and improved mobility for 80 per cent of patients." He is considering a clinical trial which could see the treatment pass through the National Institute for Health and Care Excellence (NICE) and become available on the NHS.
The therapy is still only four years old, he emphasises. "We have treated 1000 patients so far and around the world, it's about 40,000. We need longer-term studies."
Michael Schumacher has not been seen in public since suffering a serious brain injury in a skiing accident nearly six years ago.
This type of stem cell treatment is also offered in the UK for post-menopause vaginal atrophy and stress incontinence, Checkley says, plus the genital skin condition lichen sclerosis. In all these cases, he says, the mechanism is the same: the stem cells are not replicating dead or dying cells but acting as signalling devices, alerting the body that this is an area where healing is needed.
For stem cells to work in more complex conditions, they would need to be manipulated, Checkley says. In cases of brain injury or disease, that would mean altering stem cells so that they could be targeted more precisely. But he believes the role would be similar: "The idea is they would go to the area of greatest damage and signal the body to regrow tissue there."
Cost would be a huge factor, he points out. A treatment for arthritis costs about 6000 (NZ$11,700) at the Regenerative Clinic but an IV-led treatment for brain injury with manipulated stem cells could cost up to 50,000 (NZ$98,000). But then what price recovery from a traumatic brain injury? Full recovery thanks to stem cells would be a prize beyond value.
Go here to read the rest:
Reported stem cell treatment could give hope to Michael Schumacher - Stuff.co.nz
- Harvard geneticist George Church's goal: to protect humans from viruses, genetic diseases, and aging - 60 Minutes - CBS News - December 8th, 2019
- Global Stem Cell Antibody Market Executive Summary and Analysis by Top Players 2019-2025 : Thermo Fisher Scientific, Inc., Merck Group, Abcam plc,... - December 8th, 2019
- Start-up to research on degenerative eye disease - Deccan Herald - December 8th, 2019
- R&D Activities to Fast-track the Growth of the Stem Cell Assay Market Between 2018 2028 - Kentucky Reports - December 8th, 2019
- The Making of a Root - Duke Today - December 5th, 2019
- Engelhardt named 2019 Fellow of the National Academy of Inventors - Iowa Now - December 5th, 2019
- In the Spotlight: 'When you're in a minority group, you're never just a grad student' - Scope - December 5th, 2019
- Rat Model Market revenue to hit $1.8 billion by 2025: Global Market Insights, Inc. - GlobeNewswire - December 5th, 2019
- Umbilical Cord Blood (UCB) Stem Cell Market 2019 Industry Analysis focusing on Companies Analysis-Advanced Cell Technology, Athersys, California Stem... - December 5th, 2019
- Dosage analysis of the 7q11.23 Williams region identifies BAZ1B as a major human gene patterning the modern human face and underlying... - December 5th, 2019
- Stem Cell Banking Market expected to Witness a Sustainable Growth over 2028 - VaporBlash - December 5th, 2019
- Stem Cell Media Market 2019 Global Industry Insights, Innovations, Key Players Analysis, Growth Strategies and Forecast Analysis 2019 & 2026|... - December 5th, 2019
- Adult Stem Cells- Global Healthcare Research and Survey with Key Participants Celyad, Cytori Therapeutics Inc. - Planet InfoWar - December 5th, 2019
- Stem Cell Source Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 - VaporBlash - December 5th, 2019
- Global Stem Cell Therapy Contract Manufacturing Market Research 2019-2030: Source of Stem Cells, Types of Stem Cells, Size of Contract Service... - December 3rd, 2019
- Stem cell therapy shows promise for the first time in spinal cord injury - News-Medical.net - December 3rd, 2019
- Why Are We Still Funding This? The Failure of Embryonic Stem Cell Research - Christianheadlines.com - December 3rd, 2019
- New Stem Cell Research Could Make Cancer Treatments affordable and Effective for Hospitals and Patients - PRNewswire - December 3rd, 2019
- Why Do We Still Fund Embryonic Stem Cell Research That Exploits Babies and Hasn't Cured Any Patients? - LifeNews.com - December 3rd, 2019
- Fat grafting improves range of motion in limbs damaged by radiation therapy - Yahoo Finance - December 3rd, 2019
- Induced Pluripotent Stem Cells Market To Register High Revenue Growthat 7% CAGR Throughout 2018 to 2026 - Kentucky Reports - December 3rd, 2019
- Animal Stem Cell Therapy Market forecasted to surpass the value of ~US$ XX Mn/Bn by 2017 - 2025 - The Market Expedition - December 3rd, 2019
- Researchers show how the ductal system connecting digestive organs is formed - News-Medical.net - December 3rd, 2019
- Stem Cell Assay Market Estimated to Record Highest CAGR by 2017 - 2025 - The Market Expedition - December 3rd, 2019
- Autologous Stem Cell and Non Stem Based therapies Market Size SWOT Analysis of Top Key Player Forecasts To 2025 - Markets Gazette 24 - December 3rd, 2019
- Global Stem Cell Banking Storage Market 2019 by Company, Regions, Type and Application, Forecast to 2025 - Industry News Info - December 3rd, 2019
- Stem Cell Banking Market to Witness an Outstanding Growth by 2018 - 2026 - Weekly Spy - December 3rd, 2019
- Stem Cell Banking Market Advanced technologies & growth opportunities in global Industry by 2018 - 2026 - Markets Gazette 24 - December 3rd, 2019
- Global Stem Cell Banking Market with Geographic Segmentation, Demand by Regions, Statistical Forecast and Competitive Landscape Research upto... - November 30th, 2019
- How Flight Feathers Evolved: Study of Chickens, Ostriches, Penguins, Ducks and Eagles - SciTechDaily - November 30th, 2019
- Researchers discover a stem cell therapy that can help heal injured heart - ANI News - November 29th, 2019
- Revolutionizing Injury Recovery With Tendon Stem Cells - Technology Networks - November 29th, 2019
- How birds fly: New USC study examines the evolution of flight feathers - USC News - November 29th, 2019
- New Link Discovered Between Cells That Burn Fat and Colon Cancer - Clinical OMICs News - November 29th, 2019
- Systematic analysis and evaluation of Mesenchymal Stem Cells Market with share, growth rate, Forecasts to 2026 - WindStreetz - November 29th, 2019
- Umbilical Cord Blood (UCB) Stem Cell Market Outlook 2019 Industry Size, Top Key Manufacturers, Growth Insights, Demand Analysis and 2025 Forecast... - November 25th, 2019
- New Device Permits a Closer Look at Previously Inaccessible Areas of the Genome - Technology Networks - November 25th, 2019
- Omega 3 Fatty Acid Health Welfare Connected To Stem Cell Regulation Researchers Discover - News Raise - November 22nd, 2019
- Tokyo's Heartseed reaps $26M to test its stem cell injections for heart failure - FierceBiotech - November 22nd, 2019
- Junior Research Fellow for Stem Cell-Based Neural Tissue Engineering Project job with VELLORE INSTITUTE OF TECHNOLOGY | 187070 - Times Higher... - November 22nd, 2019
- CRISPR Therapeutics and Vertex: Promising Gene Therapy Data for Sickle Cell Disease and Beta Thalassemia - BioSpace - November 22nd, 2019
- Europe Stem Cell Assay Market to Witness a Pronounce Growth in Coming Years | Insights, Trends, Growth, Industry Drivers with Cellular Dynamics... - November 22nd, 2019
- Stem Cell And Regenerative Therapy Market Value Share, Analysis and Segments 2018-2024 - Crypto News Byte - November 22nd, 2019
- The science institutions hiring integrity inspectors to vet their papers - Nature.com - November 22nd, 2019
- Global Stem Cell Antibody Market: Key companies Profile, their market Share and other important parameters - Market Research Reporting - November 22nd, 2019
- Animal Stem Cell Therapy Market Application, Specification Analysis, Size and Growth 2019 To 2024 - VaporBlash - November 22nd, 2019
- Stem Cell Media Market 2019| Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2026 | Research Industry US - News Obtain - November 17th, 2019
- International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019 - Yahoo Finance - November 17th, 2019
- Quality of Life With Busulfan and Fludarabine Compared With Busulfan and Cyclophosphamide - Hematology Advisor - November 17th, 2019
- Bioethics Coming to Elementary and High Schools? - Discovery Institute - November 17th, 2019
- 'Dr. Death' and 'Bad Batch' Host Laura Beil on the Future of Podcasts - ELLE.com - November 17th, 2019
- Leading Alternative Healing Director of Total Health Institute Reviews and Receives 3rd Fellowship in Stem Cell Therapy - GlobeNewswire - November 15th, 2019
- NIST researchers use artificial intelligence for quality control of stem cell-derived tissues - National Institutes of Health - November 15th, 2019
- Modeling the early development of a primate embryo - Science Magazine - November 15th, 2019
- BREAKTHROUGH: Her vision was getting worse, then animal research made things clear - Speaking of Research - November 15th, 2019
- Stem Cell Therapy Market To Increase Exponentially During 2018 2025 - Downey Magazine - November 15th, 2019
- Stem Cell Transplants Used to Grow Fully Functional Lungs in Mice - Technology Networks - November 11th, 2019
- Human Heart Cells Transform in Space; Return to Normal on Earth: Study - The Weather Channel - November 11th, 2019
- Serving those who serve us - The Hub at Johns Hopkins - November 11th, 2019
- Kadimastem to Present Interim Results of Cohort A of Its Phase 1/2a Clinical Trial in ALS at the 7th International Stem Cell Meeting, in Tel-Aviv,... - November 11th, 2019
- The Value and Versatility of Clinical Flow Cytometry - Technology Networks - November 11th, 2019
- Global Cell Harvesting Industry Research: Key Companies Profile with Sales, Revenue, Market Share, Price and Competitive Situation Analysis - Inquiry... - November 11th, 2019
- Human heart cells are altered by spaceflight, but return mostly to normal on Earth - Space Daily - November 9th, 2019
- Jennifer OConnell: President Kanye in 2024? Be very afraid America - The Irish Times - November 9th, 2019
- Cord Blood Stem Cells Market Executive Summary, Introduction, Sizing, Analysis and Forecast To 2025 - Markets Gazette 24 - November 9th, 2019
- Global Animal Stem Cell Therapy Market - Industry Outlook and Forecast 2019-2024 - Real Viewpoint - November 9th, 2019
- Novel Molecule Reduces the Aggressiveness of Pediatric Cancer - Technology Networks - November 7th, 2019
- 2019s Allen Distinguished Investigators will focus on the mysteries of our cells - Yahoo Tech - November 7th, 2019
- At the American Academy of Stem Cell Physicians Live Congress 2019, FDA Safety Panel Says No to the Bad Actors - PRNewswire - November 7th, 2019
- MD Anderson Partners with Takeda to Develop CAR Natural Killer-Cell Therapy - Cancer Network - November 7th, 2019
- First UK patient treated with tissue engineered product for rare eye disease - Hospital Healthcare Europe - November 7th, 2019
- Spaceflight alters heart cells but they quickly recover back on Earth - New Scientist News - November 7th, 2019
- Stem Cell Assay Market To Witness Increase In Revenues By 2024 - Montana Ledger - November 7th, 2019
- Researchers Find Link Between Eye Disease And Degeneration Of The Brain - BioSpace - November 7th, 2019
- Physicians' Education Resource to Host Satellite Symposia at Annual American Society of Hematology Meeting and Exposition in Orlando - Business Wire - November 7th, 2019
- Keep Bioethics out of Elementary and High Schools - National Review - November 7th, 2019
- Stem Cell Cartilage Regeneration Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2025 - Virtualnewsusa - November 7th, 2019
- The Bold and the Beautiful Star Don Diamont Supports ALS Research - Soap Hub - November 7th, 2019
- International Conference on Stem Cells and Regenerative Medicine - Hoover Sun - November 5th, 2019
- Global Cancer Stem Cell Market Forecast to 2024 by Types, Application and by Regions - Exchange 99 - November 5th, 2019